NRC vs VEEV
NRC: NRC Health offers an AI-powered healthcare experience management platform designed to help organizations improve patient and employee engagement through deep human insights. VEEV: Veeva is the dominant cloud software and data platform powering the global life sciences industry from drug development through commercialization, with AI-enhanced solutions and a 16% annual revenue growth trajectory.
Side-by-side fundamentals
| Metric | NRC | VEEV | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $19.51 | $203.78 | |
| Market cap as of 2026-08-03 | $440M | $33.1B | |
| P/E as of 2026-08-03 | 47.47 | 36.05 | VEEV lower |
| PEG as of 2026-08-03 | n/a | 1.89 | |
| Net margin as of 2026-08-03 | +6.5% | +28.4% | VEEV higher |
| Gross margin as of 2026-08-03 | +61.8% | +75.0% | VEEV higher |
| Operating margin as of 2026-08-03 | +14.1% | +28.8% | VEEV higher |
| ROE as of 2026-08-03 | +57.3% | +13.4% | NRC higher |
| ROA as of 2026-08-03 | +6.6% | +11.0% | VEEV higher |
| Debt / equity as of 2026-08-03 | 5.78 | 0.00 | VEEV lower |
| Revenue growth (YoY) as of 2026-08-03 | -1.9% | +16.3% | VEEV higher |
| Revenue CAGR (3y) SEC XBRL | -3.2% | +14.0% | VEEV higher |
| Dividend yield as of 2026-08-03 | +3.3% | n/a | |
| Dividend streak (yrs) SEC XBRL | 2 | n/a | |
| Beta as of 2026-08-03 | 0.88 | 0.64 | |
| 1-year return as of 2026-07-31 close | +56.1% | -28.3% | NRC higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.